sharon sanders
Editor-in-Chief & President
A large tertiary specialized hospital suddenly announced the suspension of its services!
July 3, 2026, 18:38,
On July 1st, Chongqing Kangxin Hospital's official WeChat account suddenly announced a suspension of services. The announcement stated that due to operational adjustments, the hospital would cease all medical and ancillary services from 8:00 PM on June 30th, 2026.The resumption date would be announced on the Kangxin Hospital WeChat account.
Public information shows that Chongqing Kangxin Hospital is one of the earliest large-scale private cardiovascular disease hospitals in Chongqing. Founded in 2016, the hospital covers an area of over 30 acres, with a planned building area of approximately 100,000 square meters, 800 planned beds, and a total investment of approximately 1.2 billion yuan.
According to its official website, Kangxin Hospital aims to "strengthen specialized departments and improve comprehensive services." Its medical team consists of senior experts from nationally renowned tertiary teaching hospitals, including the affiliated hospitals of Army Medical University (Southwest Hospital, Xinqiao Hospital, and Daping Hospital), the Northern Theater Command General Hospital, and Beijing Anzhen Hospital affiliated with Capital Medical University.
In December 2020, the Chongqing Municipal Health Commission organized experts to conduct an acceptance review of the 2018 municipal-level key clinical specialty construction projects. The Department of Cardiology of Chongqing Kangxin Hospital passed the acceptance review and became a municipal-level key clinical specialty construction project.
Previously, Kangxin Hospital was a hospital under Kanghua Medical (03689.HK), a Hong Kong-listed company.
According to Kanghua Medical's announcements, in June 2018, Kanghua Medical acquired a 60% stake in Chongqing Zhonglian Cardiovascular Hospital for RMB 270 million. The hospital was later renamed Chongqing Kanghua Zhonglian Cardiovascular Hospital, also known as Chongqing Kangxin Hospital. In May 2023, Kanghua Medical announced another acquisition, this time for RMB 108 million, to acquire the remaining 40% stake in Kangxin Hospital. Following these two acquisitions, Kanghua Medical held 100% ownership of Chongqing Kangxin Hospital.
However, in the following two years, Kanghua Medicaqingl issued a series of announcements, transferring its 100% stake in Chongqing Kangxin Hospital in two separate transactions. In January 2025, Kanghua Medical sold 55% of its stake in Kangxin Hospital for nearly 35 million yuan; in April 2026, it sold the remaining 45% stake for 14 million yuan.
In its announcement, Kanghua Medical disclosed that, due to the continued underperformance of Kangxin Hospital compared to management's expectations, and given the increasingly fierce competition in the Chongqing medical market, the board of directors, after careful consideration, believes that continued investment from existing shareholders is neither the best solution for the long-term development of Kangxin Hospital nor in the best interests of the company and its shareholders as a whole. To optimize the allocation of internal resources and ensure its long-term sustainable development, the company has decided to adjust its strategic focus by introducing investors into Kangxin Hospital and exiting its investment through a share transfer.
According to Qichacha, Chongqing Kanghua Zhonglian Cardiovascular Hospital had 312 employees enrolled in social insurance in 2024.
zhttps://k.sina.com.cn/article_5953190046_162d6789e06703fs0y.html
July 3, 2026, 18:38,
On July 1st, Chongqing Kangxin Hospital's official WeChat account suddenly announced a suspension of services. The announcement stated that due to operational adjustments, the hospital would cease all medical and ancillary services from 8:00 PM on June 30th, 2026.The resumption date would be announced on the Kangxin Hospital WeChat account.
Public information shows that Chongqing Kangxin Hospital is one of the earliest large-scale private cardiovascular disease hospitals in Chongqing. Founded in 2016, the hospital covers an area of over 30 acres, with a planned building area of approximately 100,000 square meters, 800 planned beds, and a total investment of approximately 1.2 billion yuan.
According to its official website, Kangxin Hospital aims to "strengthen specialized departments and improve comprehensive services." Its medical team consists of senior experts from nationally renowned tertiary teaching hospitals, including the affiliated hospitals of Army Medical University (Southwest Hospital, Xinqiao Hospital, and Daping Hospital), the Northern Theater Command General Hospital, and Beijing Anzhen Hospital affiliated with Capital Medical University.
In December 2020, the Chongqing Municipal Health Commission organized experts to conduct an acceptance review of the 2018 municipal-level key clinical specialty construction projects. The Department of Cardiology of Chongqing Kangxin Hospital passed the acceptance review and became a municipal-level key clinical specialty construction project.
Previously, Kangxin Hospital was a hospital under Kanghua Medical (03689.HK), a Hong Kong-listed company.
According to Kanghua Medical's announcements, in June 2018, Kanghua Medical acquired a 60% stake in Chongqing Zhonglian Cardiovascular Hospital for RMB 270 million. The hospital was later renamed Chongqing Kanghua Zhonglian Cardiovascular Hospital, also known as Chongqing Kangxin Hospital. In May 2023, Kanghua Medical announced another acquisition, this time for RMB 108 million, to acquire the remaining 40% stake in Kangxin Hospital. Following these two acquisitions, Kanghua Medical held 100% ownership of Chongqing Kangxin Hospital.
However, in the following two years, Kanghua Medicaqingl issued a series of announcements, transferring its 100% stake in Chongqing Kangxin Hospital in two separate transactions. In January 2025, Kanghua Medical sold 55% of its stake in Kangxin Hospital for nearly 35 million yuan; in April 2026, it sold the remaining 45% stake for 14 million yuan.
In its announcement, Kanghua Medical disclosed that, due to the continued underperformance of Kangxin Hospital compared to management's expectations, and given the increasingly fierce competition in the Chongqing medical market, the board of directors, after careful consideration, believes that continued investment from existing shareholders is neither the best solution for the long-term development of Kangxin Hospital nor in the best interests of the company and its shareholders as a whole. To optimize the allocation of internal resources and ensure its long-term sustainable development, the company has decided to adjust its strategic focus by introducing investors into Kangxin Hospital and exiting its investment through a share transfer.
According to Qichacha, Chongqing Kanghua Zhonglian Cardiovascular Hospital had 312 employees enrolled in social insurance in 2024.
zhttps://k.sina.com.cn/article_5953190046_162d6789e06703fs0y.html